Insights on Varian’s Acquisition Deal with Sirtex Medical
On January 30, Varian Medical Systems (VAR) entered into an agreement to acquire Australian company Sirtex Medical for $1.2 billion, at 28 Australian dollars per share. Sirtex Medical is a global life sciences company with a focus on interventional oncology therapies. Varian plans to fund the acquisition primarily through its 2018 revolving credit facility.